Literature DB >> 11889247

Accuracy of muscle localization without EMG: implications for treatment of limb dystonia.

F M Molloy1, H A Shill, A Kaelin-Lang, B I Karp.   

Abstract

Although botulinum toxin is an effective treatment for focal dystonia, the importance of electromyography (EMG) in identifying muscles and guiding injections is unclear. The authors examined the accuracy of muscle localization in 38 muscles in patients with focal hand dystonia without EMG guidance. Only 37% of needle placement attempts reached the target muscles or muscle fascicles. This study demonstrates that EMG guidance is needed for correct localization of desired muscles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889247     DOI: 10.1212/wnl.58.5.805

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

Review 1.  Botulinum toxin in clinical practice.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

Review 2.  Botulinum toxin for the treatment of movement disorders.

Authors:  Mary Ann Thenganatt; Stanley Fahn
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

3.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

4.  Botulinum Toxin in the Treatment of Pediatric Upper Limb Spasticity.

Authors:  Aloysia L Schwabe
Journal:  Semin Plast Surg       Date:  2016-02       Impact factor: 2.314

5.  Accuracy of non-guided versus ultrasound-guided injections in cervical muscles: a cadaver study.

Authors:  Alexandre Kreisler; Camille Gerrebout; Luc Defebvre; Xavier Demondion
Journal:  J Neurol       Date:  2021-01-05       Impact factor: 4.849

6.  Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more.

Authors:  Codrin Lungu; Barbara I Karp; Katharine Alter; Regina Zolbrod; Mark Hallett
Journal:  Mov Disord       Date:  2011-02-01       Impact factor: 10.338

7.  Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  D M Simpson; A Blitzer; A Brashear; C Comella; R Dubinsky; M Hallett; J Jankovic; B Karp; C L Ludlow; J M Miyasaki; M Naumann; Y So
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

8.  Chemical components separation with botulinum toxin A: a novel technique to improve primary fascial closure rates of the open abdomen.

Authors:  M D Zielinski; N Goussous; H J Schiller; D Jenkins
Journal:  Hernia       Date:  2012-09-22       Impact factor: 4.739

Review 9.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

Review 10.  Treatment of focal dystonias with botulinum neurotoxin.

Authors:  Mark Hallett; Reiner Benecke; Andrew Blitzer; Cynthia L Comella
Journal:  Toxicon       Date:  2008-12-13       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.